04:50 PM, 24th Feb 2026
The Exchange has sought clarification from Natco Pharma Ltd on February 24 2026 with reference to news appeared in https://www.livemint.com dated February 24 2026 quoting Eris Lifesciences inks deal with Natco Pharma for weight-loss drug semaglutide. <BR><BR>The reply is awaited.